References
- Ogilvy S, Metcalf D, Print CG, Bath ML, Harris AW, Adams JM. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci U S A 1999; 96:14943 - 8; http://dx.doi.org/10.1073/pnas.96.26.14943; PMID: 10611317
- Schuster C, Berger A, Hoelzl MA, Putz EM, Frenzel A, Simma O, et al. The cooperating mutation or “second hit” determines the immunologic visibility toward MYC-induced murine lymphomas. Blood 2011; 118:4635 - 45; http://dx.doi.org/10.1182/blood-2010-10-313098; PMID: 21878673
- Champsaur M, Lanier LL. Effect of NKG2D ligand expression on host immune responses. Immunol Rev 2010; 235:267 - 85; PMID: 20536569
- Trisciuoglio D, Gabellini C, Desideri M, Ragazzoni Y, De Luca T, Ziparo E, et al. Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells. Cell Death Differ 2011; 18:1024 - 35; http://dx.doi.org/10.1038/cdd.2010.175; PMID: 21233846
- Gough DJ, Corlett A, Schlessinger K, Wegrzyn J, Larner AC, Levy DE. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 2009; 324:1713 - 6; http://dx.doi.org/10.1126/science.1171721; PMID: 19556508
- Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004; 305:626 - 9; http://dx.doi.org/10.1126/science.1099320; PMID: 15286356
- Häcki J, Egger L, Monney L, Conus S, Rossé T, Fellay I, et al. Apoptotic crosstalk between the endoplasmic reticulum and mitochondria controlled by Bcl-2. Oncogene 2000; 19:2286 - 95; http://dx.doi.org/10.1038/sj.onc.1203592; PMID: 10822379
- Kaufmann T, Schlipf S, Sanz J, Neubert K, Stein R, Borner C. Characterization of the signal that directs Bcl-x(L), but not Bcl-2, to the mitochondrial outer membrane. J Cell Biol 2003; 160:53 - 64; http://dx.doi.org/10.1083/jcb.200210084; PMID: 12515824
- Shirane M, Nakayama KI. Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat Cell Biol 2003; 5:28 - 37; http://dx.doi.org/10.1038/ncb894; PMID: 12510191
- Zitvogel L, Apetoh L, Ghiringhelli F, André F, Tesniere A, Kroemer G. The anticancer immune response: indispensable for therapeutic success?. J Clin Invest 2008; 118:1991 - 2001; http://dx.doi.org/10.1172/JCI35180; PMID: 18523649